Market Segmentation Drug Class Insights (Revenue, USD Bn, 2021 - 2033) Exenatide Liraglutide Dulaglutide Lixisenatide Albiglutide Semaglutide Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) Parenteral Oral Application Insights (Revenue, USD Bn, 2021 - 2033) Type 2 Diabetes Mellitus Obesity Liver Cirrhosis Non-alcoholic Steatohepatitis Others Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional Insights (Revenue, USD Bn, 2021 - 2033) North America U.S
34 FalkowskaA.GutowskaI.GoschorskaM.NowackiP.ChlubekD.Baranowska-BosiackaI
Avoid stopping or changing doses without talking to your clinician
Its often praised for being gentle on the stomach, and others like that it works even without strict skincare regimens
Nat Rev Endocrinol 21:482494